EPISODE · Jul 7, 2026 · 1H 27M
Martin Shkreli on Drug Pricing, Prison, and the Fraud That Shook Pharma
from The Doctor's Lounge · host The Doctor's Lounge
Send us Fan MailEpisode SummaryAnish Koka and Anthony DiGiorgio sit down with Martin Shkreli — the former hedge fund manager and pharma executive best known for the 2015 Daraprim price increase and his subsequent prison sentence — for a wide-ranging conversation on drug pricing, patent law, and the state of the pharmaceutical industry. Shkreli walks through his path from a teenage hedge fund intern to founding Retrophin and Turing Pharmaceuticals, defends orphan drug economics and the Orphan Drug Act's seven-year exclusivity window, and argues that patent terms haven't kept pace with the realities of modern drug development. The conversation turns to the Chemocentrics/Amgen scandal — in which trial data for a rare vasculitis drug was allegedly unblinded, manipulated, and relocked to manufacture statistical significance — which Shkreli calls one of the worst frauds in the history of medicine. The episode closes with discussion of the Sarepta/DMD approval controversy, the limits of randomized trials in surgery and rare disease, AI's parallels to neuroscience, and the state of media coverage of the FDA.Chapter Markers00:00 Intro and Martin Shkreli's backstory02:40 Origin story: from hedge fund to founding drug companies07:58 The Daraprim price increase and Shkreli's pricing philosophy17:14 What it actually takes to bring a drug to market35:25 The case for the pharmaceutical industry38:00 The Orphan Drug Act and patent exclusivity57:31 The Chemocentrics scandal: manipulated trial data at Amgen1:22:09 Vinay Prasad, Sarepta, and the DMD approval fights1:34:35 Neurosurgery, clinical trials, and the limits of RCTs1:37:30 AI, neural networks, and the future of psychiatric drugs1:40:40 Cardiovascular disease and LDL lowering1:42:28 Media coverage of the FDA and closing thoughtsCo-Host Handles@anish_koka and @drdigiorgioShow Handles@drsloungepodSubscribe LinksSpotify: https://open.spotify.com/show/44vw8eirsKKnjgNIrdDvrRApple Podcasts: https://podcasts.apple.com/us/podcast/the-doctors-lounge/id1832097658YouTube: https://www.youtube.com/@TheDoctorsLoungePod🔗 Connect with the Hosts:• Dutch Rojas on X• Dr. Anthony DiGiorgio on X• Dr. Anish Koka on X• Dr. Dan Choi on X• Dr. Sanat Dixit on X
Embed this episode
What this episode covers
Send us Fan Mail Episode SummaryAnish Koka and Anthony DiGiorgio sit down with Martin Shkreli — the former hedge fund manager and pharma executive best known for the 2015 Daraprim price increase and his subsequent prison sentence — for a wide-ranging conversation on drug pricing, patent law, and the state of the pharmaceutical industry. Shkreli walks through his path from a teenage hedge fund intern to founding Retrophin and Turing Pharmaceuticals, defends orphan drug economics and the Orphan...
NOW PLAYING
Martin Shkreli on Drug Pricing, Prison, and the Fraud That Shook Pharma
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.